Categories: BuildingCauseDataDrugInvestmentManufacturingMapsMedtechPlatformSupply
Mantias maps and predicts the evolution of global pharmaceutical production networks — high-resolution structural intelligence for supply chain resilience.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 12.06.2026 | MassChallenge Switzerland selects its 2026 accelerator cohort |
MassChallenge Switzerland has selected the startups for its 2026 early-stage accelerator, a four-month programme that takes no equity in the companies it supports. Launched in 2016 and based in Renens (Vaud), the accelerator chose its coho... |
Reviews 0
